AXON exceeded expectations after hours, but the stock was down, probably due to announcement to by DeDrone. I thought they already had drones in their portfolio, but DeDrone sounds like it can also take out the bad drones as noted in this quote by the CEO…
"Together, we will accelerate our efforts in creating a more advanced end-to-end drone solution that enables the good drones to fly and helps ensure the bad ones don’t," CEO Rick Smith said in a statement.
If they can easily disable bad drones, that is good for the police. Note that drones were used in some of the protest clashes to make sure cops were not going to be ambushed. Not sure if those were AXON, but all the body cam footage wash.
I have always loved the Evidence.com component, which is a subscription service to properly store footage so it holds up in court.
They announce a generative AI component to Evidence.com that should really add to earnings going forward (you know it ain’t free).
Axon already cleared an early entry last week on momentum from its April 21-25 Axon Week event, highlighted by the unveiling of Draft One. The generative AI takes audio input that has been uploaded to the cloud from officers’ body cameras to create a first draft of field reports “in literally just seconds,” William Blair analyst Jonathan Ho wrote in an April 24 report.
“Axon believes it can save an average of an hour per day in report writing per officer,” Ho wrote. He added that Draft One may incorporate video from body cameras to augment reports in the future.
JMP securities is bullish on Axon VR training to grow the adoption of the Taser 10 product.
Estimates: Analysts expected Axon earnings per share to rise 8% to 95 cents, according to the FactSet consensus. Revenue was seen rising 29% to $441.6 million.
Results: Axon earnings grew 31% to $1.15 a share, 20 cents ahead of forecasts. Revenue jumped 34% to $460.7 million.
Outlook: For the full year, Axon raised its revenue outlook to a range of $1.94 billion to $1.99 billion from a prior range of $1.88 billion to $1.94 billion.
Axon bumped up its capital spending plan to a range of $80 million to $95 million from $60 million to $75 million as it accelerates its capacity expansion to meet higher demand for its newest Taser.
Pete